Outcome: Dismissed
FEB262026_01B5203
Our summary
Biotechnology researcher proposes developing genomic editing tools for disease modeling and gene therapy targeting neurodegenerative and autoimmune disorders. AAO found the endeavor has substantial merit but rejected it because the record fails to establish the proposed endeavor's prospective impact or national importance, relying instead on general industry importance.
Official PDF
Official PDF ↗Published by USCIS. The summary is ours, in our own words; the decision text is on uscis.gov.
What the AAO accepted
- Merit and national importance · AAO found proposed endeavor in genomic editing and gene therapy for disease treatment has substantial merit
What was missing
Every criterion in the table was found met.
Criteria
| Criterion | Reading | Why |
|---|---|---|
| Met | AAO found proposed endeavor in genomic editing and gene therapy for disease treatment has substantial merit | |
| Not reached / not discussed | Not reached because first prong failed on national importance; remaining prongs reserved | |
| Not reached / not discussed | Not reached because first prong failed; balance analysis reserved |
A published decision describes one case. It is not legal advice and not a prediction for yours.
